LeonaBio, Inc.
LONA
$11.26
$0.262.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.77M | 4.05M | 3.63M | 5.23M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.48M | 6.87M | 7.29M | 9.54M | 15.57M |
| Operating Income | -10.48M | -6.87M | -7.29M | -9.54M | -15.57M |
| Income Before Tax | -82.89M | -6.61M | -6.97M | -9.14M | -15.00M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -82.89M | -6.61M | -6.97M | -9.14M | -15.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.89M | -6.61M | -6.97M | -9.14M | -15.00M |
| EBIT | -10.48M | -6.87M | -7.29M | -9.54M | -15.57M |
| EBITDA | -10.23M | -6.63M | -7.05M | -9.29M | -15.32M |
| EPS Basic | -15.51 | -1.68 | -1.78 | -2.34 | -3.88 |
| Normalized Basic EPS | -1.74 | -1.05 | -1.11 | -1.47 | -2.43 |
| EPS Diluted | -15.51 | -1.68 | -1.78 | -2.34 | -3.88 |
| Normalized Diluted EPS | -1.74 | -1.05 | -1.11 | -1.47 | -2.43 |
| Average Basic Shares Outstanding | 5.35M | 3.94M | 3.91M | 3.90M | 3.87M |
| Average Diluted Shares Outstanding | 5.35M | 3.94M | 3.91M | 3.90M | 3.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |